This hyperactivates downstream pathways—notably MAPK (RAS-RAF-MEK-ERK) and PI3K-AKT-mTOR—to drive tumor growth by enhancing proliferation, survival, and metastasis. Here, MAP2K7 is linked to neoplasm.